74 results
8-K
EX-99.1
KAYS
Kaya Holdings, Inc.
28 Nov 23
Regulation FD Disclosure
5:31pm
with the planned introduction of psilocybin treatment centers through our majority owned subsidiary, Fifth Dimension Therapeutics, Inc. ("FDT").
About
8-K
EX-99.1
KAYS
Kaya Holdings, Inc.
9 Nov 23
Regulation FD Disclosure
8:30am
ground in the United States with the planned introduction of psilocybin treatment centers through our majority owned subsidiary, Fifth Dimension
8-K
EX-99.1
KAYS
Kaya Holdings, Inc.
23 Oct 23
KAYS’ Oregon Based Psilocybin Treatment Center is on track to be the first of its kind operated by a U.S. Public Company
4:15pm
of psilocybin treatment centers through our majority owned subsidiary, Fifth Dimension Therapeutics, Inc. (“FDT”).
KAYS subsidiaries include:
Fifth
8-K
EX-99.1
emb8o27um m1yv
3 Oct 23
State-of-the-Art Facility to Offer Access to Psilocybin Treatments
7:48am
S-8
EX-10.1
qummqj96 nl7b
15 Sep 22
Registration of securities for employees
4:06pm
8-K
butc3lxenfd
7 Jul 22
Other Events
1:10pm
8-K
EX-99.1
mogjm0y14ca3
7 Jul 22
Other Events
1:10pm
8-K
EX-3.1
aw7yqduzmgyh1gy9c
29 Dec 21
Departure of Directors or Certain Officers
2:43pm